Ongoing research aims to better understand the complex role of GSTs in cancer biology. Advances in precision medicine and personalized therapy may allow for more tailored approaches in targeting GSTs. Combining GST inhibitors with conventional chemotherapy could potentially improve treatment outcomes for patients with drug-resistant cancers.